Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

Kimball Electronics Q1 2026 Results: Net Income $2.64M, Down 73.8% YoY

For the quarter ended September 30, 2026, Kimball Electronics reported net sales of $390.8 million, a 7% increase year-over-year, though net income fell significantly to $2.6 million from $10.1 million due to higher operating expenses and a sharp increase in the provision for income taxes. The company also completed a major acquisition during the period, resulting in a substantial increase in goodwill and long-term debt.

Watch the Kimball Electronics, Inc. earnings callFull call on the ALFA USA YouTube channel
Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue390.8365.6
Gross profit30.928.8
Profit before tax7.811.0
Net income2.610.1
EPS (diluted, $ a share)$0.11$0.40

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-73.8%
Revenue, year on year+6.9%
Gross margin7.9%
Operating margin3.2%
Source

10-Q filed with the SEC, NASDAQ: KE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Kimball Electronics, Inc.: key numbers

Share price
$18.86Close, Nov 16
Market cap
$452M
Shares outstanding
23.98MLatest SEC cover page
Sector
Manufacturing
Industry
Printed Circuit BoardsSIC 3672

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Kimball Electronics, Inc.

All →
4:37 PM ET 8-K
Financial Results

Kimball Electronics Financial Results

Kimball Electronics reported Q1 fiscal 2027 net sales of $390.8 million, a 7% year-over-year increase driven by 14% growth in the Medical vertical. The company reiterated its full-year fiscal 2027 guidance, noting that sales are expected to reach the high end of the $1,535 - $1,560 million range.

Term
Q1 2027

“I’m encouraged by our first quarter results and solid start to fiscal 2027. Sales increased both sequentially and year-over-year, margins were healthy, and cash conversion days were once again at a multiyear low. The top line benefited from organic sales growth and the contribution from Helvoet Polymer Technologies, our recent tuck-in acquisition in the medical CDMO.”

Richard D. Phillips, Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.